Woodline Partners’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.8M | Sell |
870,208
-190,845
| -18% | -$8.29M | 0.2% | 144 |
|
|
2025
Q1 | $39.6M | Buy |
1,061,053
+45,445
| +4% | +$1.7M | 0.26% | 118 |
|
|
2024
Q4 | $46M | Buy |
1,015,608
+39,453
| +4% | +$1.79M | 0.31% | 90 |
|
|
2024
Q3 | $57.3M | Buy |
976,155
+229,996
| +31% | +$13.5M | 0.48% | 51 |
|
|
2024
Q2 | $29.4M | Buy |
746,159
+43,738
| +6% | +$1.72M | 0.28% | 113 |
|
|
2024
Q1 | $46.7M | Buy |
702,421
+376,319
| +115% | +$25M | 0.43% | 62 |
|
|
2023
Q4 | $9.11M | Buy |
326,102
+16,102
| +5% | +$450K | 0.1% | 237 |
|
|
2023
Q3 | $6.6M | Buy |
+310,000
| New | +$6.6M | 0.08% | 275 |
|